PURPOSE: To report our institution's experience using prone positioning for three-dimensional conformal radiotherapy (3D-CRT) to deliver post-lumpectomy whole breast irradiation (WBI) in a cohort of women with large and/or pendulous breasts, to determine the rate of acute and late toxicities and, more specifically, cosmetic outcomes. We hypothesized that using 3D-CRT for WBI in the prone position would reduce or eliminate patient and breast size as negative prognostic indicators for toxicities associated with WBI. METHODS AND MATERIALS: From 1998 to 2006, 110 cases were treated with prone WBI using 3D-CRT. The lumpectomy, breast target volumes, heart, and lung were contoured on all computed tomography scans. A dose of 45-50 Gy was prescribed to the breast volume using standard fractionation schemes. The planning goals were ≥95% of prescription to 95% of the breast volume, and 100% of boost dose to 95% of lumpectomy planning target volume. Toxicities and cosmesis were prospectively scored using the Common Terminology Criteria for Adverse Effects Version 3.0 and the Harvard Scale. The median follow-up was 40 months. RESULTS: The median body mass index (BMI) was 33.6 kg/m(2), and median breast volume was 1396 cm(3). The worst toxicity encountered during radiation was Grade 3 dermatitis in 5% of our patient population. Moist desquamation occurred in 16% of patients, with only 2% of patients with moist desquamation outside the inframammary/axillary folds. Eleven percent of patients had Grade ≥2 late toxicities, including Grade 3 induration/fibrosis in 2%. Excellent to good cosmesis was achieved in 89%. Higher BMI was associated with moist desquamation and breast pain, but BMI and breast volume did not impact fibrosis or excellent to good cosmesis. CONCLUSION: In patients with higher BMI and/or large-pendulous breasts, delivering prone WBI using 3D-CRT results in favorable toxicity profiles and high excellent to good cosmesis rates. Higher BMI was associated with moist desquamation, but prone positioning removed BMI and breast size as factors for poorer cosmetic outcomes. This series adds to the growing literature demonstrating that prone WBI may be advantageous in select patients.
PURPOSE: To report our institution's experience using prone positioning for three-dimensional conformal radiotherapy (3D-CRT) to deliver post-lumpectomy whole breast irradiation (WBI) in a cohort of women with large and/or pendulous breasts, to determine the rate of acute and late toxicities and, more specifically, cosmetic outcomes. We hypothesized that using 3D-CRT for WBI in the prone position would reduce or eliminate patient and breast size as negative prognostic indicators for toxicities associated with WBI. METHODS AND MATERIALS: From 1998 to 2006, 110 cases were treated with prone WBI using 3D-CRT. The lumpectomy, breast target volumes, heart, and lung were contoured on all computed tomography scans. A dose of 45-50 Gy was prescribed to the breast volume using standard fractionation schemes. The planning goals were ≥95% of prescription to 95% of the breast volume, and 100% of boost dose to 95% of lumpectomy planning target volume. Toxicities and cosmesis were prospectively scored using the Common Terminology Criteria for Adverse Effects Version 3.0 and the Harvard Scale. The median follow-up was 40 months. RESULTS: The median body mass index (BMI) was 33.6 kg/m(2), and median breast volume was 1396 cm(3). The worst toxicity encountered during radiation was Grade 3 dermatitis in 5% of our patient population. Moist desquamation occurred in 16% of patients, with only 2% of patients with moist desquamation outside the inframammary/axillary folds. Eleven percent of patients had Grade ≥2 late toxicities, including Grade 3 induration/fibrosis in 2%. Excellent to good cosmesis was achieved in 89%. Higher BMI was associated with moist desquamation and breast pain, but BMI and breast volume did not impact fibrosis or excellent to good cosmesis. CONCLUSION: In patients with higher BMI and/or large-pendulous breasts, delivering prone WBI using 3D-CRT results in favorable toxicity profiles and high excellent to good cosmesis rates. Higher BMI was associated with moist desquamation, but prone positioning removed BMI and breast size as factors for poorer cosmetic outcomes. This series adds to the growing literature demonstrating that prone WBI may be advantageous in select patients.
Authors: M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang Journal: Lancet Date: 2005-12-17 Impact factor: 79.321
Authors: A M Moody; W P Mayles; J M Bliss; R P A'Hern; J R Owen; J Regan; B Broad; J R Yarnold Journal: Radiother Oncol Date: 1994-11 Impact factor: 6.280
Authors: Gary M Freedman; Penny R Anderson; Jinsheng Li; Debra F Eisenberg; Alexandra L Hanlon; Lu Wang; Nicos Nicolaou Journal: Am J Clin Oncol Date: 2006-02 Impact factor: 2.339
Authors: D E Wazer; T DiPetrillo; R Schmidt-Ullrich; L Weld; T J Smith; D J Marchant; N J Robert Journal: J Clin Oncol Date: 1992-03 Impact factor: 44.544
Authors: M E Taylor; C A Perez; K J Halverson; R R Kuske; G W Philpott; D M Garcia; J E Mortimer; R J Myerson; D Radford; C Rush Journal: Int J Radiat Oncol Biol Phys Date: 1995-02-15 Impact factor: 7.038
Authors: Ursula Hille-Betz; Bernhard Vaske; Michael Bremer; Philipp Soergel; Sudip Kundu; Rüdiger Klapdor; Peter Hillemanns; Christoph Henkenberens Journal: Strahlenther Onkol Date: 2015-09-28 Impact factor: 3.621
Authors: Carmen Bergom; Tracy Kelly; Meena Bedi; Hina Saeed; Phillip Prior; Lisa E Rein; Aniko Szabo; J Frank Wilson; Adam D Currey; Julia White Journal: Int J Radiat Oncol Biol Phys Date: 2016-04-23 Impact factor: 7.038
Authors: Rachel A Schlaak; Anne Frei; Brian L Fish; Leanne Harmann; Tracy Gasperetti; Jamie L Pipke; Yunguang Sun; Hallgeir Rui; Michael J Flister; Benjamin N Gantner; Carmen Bergom Journal: Cancers (Basel) Date: 2020-04-16 Impact factor: 6.639
Authors: Carmen Bergom; Jason Rubenstein; J Frank Wilson; Aimee Welsh; El-Sayed H Ibrahim; Phillip Prior; Aronne M Schottstaedt; Daniel Eastwood; Mei-Jie Zhang; Adam Currey; Lindsay Puckett; Jennifer L Strande; Julie A Bradley; Julia White Journal: Front Oncol Date: 2020-10-16 Impact factor: 6.244